These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 8757944

  • 1. Bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis.
    Lee RK, Spielman J, Podack ER.
    Int Immunol; 1996 Jul; 8(7):991-1000. PubMed ID: 8757944
    [Abstract] [Full Text] [Related]

  • 2. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ.
    J Immunol; 2002 Apr 01; 168(7):3484-92. PubMed ID: 11907109
    [Abstract] [Full Text] [Related]

  • 3. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K.
    J Immunol; 1996 May 15; 156(10):3678-86. PubMed ID: 8621902
    [Abstract] [Full Text] [Related]

  • 4. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
    Williams NS, Engelhard VH.
    J Immunol; 1996 Jan 01; 156(1):153-9. PubMed ID: 8598456
    [Abstract] [Full Text] [Related]

  • 5. Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2.
    Schröter M, Lowin B, Borner C, Tschopp J.
    Eur J Immunol; 1995 Dec 01; 25(12):3509-13. PubMed ID: 8566045
    [Abstract] [Full Text] [Related]

  • 6. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
    Caldwell SA, Ryan MH, McDuffie E, Abrams SI.
    J Immunol; 2003 Sep 01; 171(5):2402-12. PubMed ID: 12928387
    [Abstract] [Full Text] [Related]

  • 7. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
    Yang S, Haluska FG.
    J Immunol; 2004 Apr 01; 172(7):4599-608. PubMed ID: 15034078
    [Abstract] [Full Text] [Related]

  • 8. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
    Bergmann-Leitner ES, Abrams SI.
    J Immunol; 2000 May 01; 164(9):4941-54. PubMed ID: 10779805
    [Abstract] [Full Text] [Related]

  • 9. Fas ligand-mediated bystander lysis of syngeneic cells in response to an allogeneic stimulus.
    Smyth MJ.
    J Immunol; 1997 Jun 15; 158(12):5765-72. PubMed ID: 9190927
    [Abstract] [Full Text] [Related]

  • 10. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
    Medana I, Li Z, Flügel A, Tschopp J, Wekerle H, Neumann H.
    J Immunol; 2001 Jul 15; 167(2):674-81. PubMed ID: 11441070
    [Abstract] [Full Text] [Related]

  • 11. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
    Lee RK, Spielman J, Zhao DY, Olsen KJ, Podack ER.
    J Immunol; 1996 Sep 01; 157(5):1919-25. PubMed ID: 8757310
    [Abstract] [Full Text] [Related]

  • 12. IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms.
    Smith DJ, McGuire MJ, Tocci MJ, Thiele DL.
    J Immunol; 1997 Jan 01; 158(1):163-70. PubMed ID: 8977187
    [Abstract] [Full Text] [Related]

  • 13. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T, Miyake Y, Kakeya H, Osada H, Kataoka T.
    J Immunol; 2004 Mar 15; 172(6):3428-36. PubMed ID: 15004142
    [Abstract] [Full Text] [Related]

  • 14. Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways.
    Smyth MJ, Sutton VR, Kershaw MH, Trapani JA.
    Transplantation; 1996 Nov 27; 62(10):1529-32. PubMed ID: 8958289
    [Abstract] [Full Text] [Related]

  • 15. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo.
    Smyth MJ, Kershaw MH, Trapani JA.
    Transplantation; 1997 Apr 27; 63(8):1171-8. PubMed ID: 9133481
    [Abstract] [Full Text] [Related]

  • 16. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
    Zhou S, Ou R, Huang L, Moskophidis D.
    J Virol; 2002 Jan 27; 76(2):829-40. PubMed ID: 11752172
    [Abstract] [Full Text] [Related]

  • 17. Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.
    Hishii M, Kurnick JT, Ramirez-Montagut T, Pandolfi F.
    Clin Exp Immunol; 1999 Jun 27; 116(3):388-94. PubMed ID: 10361224
    [Abstract] [Full Text] [Related]

  • 18. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
    Nomi H, Tashiro-Yamaji J, Yamamoto Y, Miura-Takeda S, Miyoshi-Higashino M, Takahashi T, Azuma H, Ueda H, Katsuoka Y, Kubota T, Yoshida R.
    J Immunol; 2007 Aug 15; 179(4):2180-6. PubMed ID: 17675477
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis.
    Simon MM, Waring P, Lobigs M, Nil A, Tran T, Hla RT, Chin S, Müllbacher A.
    J Immunol; 2000 Oct 01; 165(7):3663-72. PubMed ID: 11034370
    [Abstract] [Full Text] [Related]

  • 20. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI, Brown GR, Thiele DL.
    J Immunol; 2001 Aug 01; 167(3):1566-74. PubMed ID: 11466378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.